Covishield | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Saturday
September 13, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SATURDAY, SEPTEMBER 13, 2025

Covishield

Covishield

Photo :UNB

Serum Institute, Bill Gates get Bombay high court notice as petitioner claims Covishield killed his daughter

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo

India gives conditional market nod for Covishield and Covaxin

A woman reacts as she receives a dose of the COVISHIELD vaccine, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, in an alley at a slum area in Ahmedabad, India, September 28, 2021. REUTERS/Amit Dave

India rules out reducing gap between Covishield doses

Serum sends 10 lakh Covishield doses after 7-month halt

Serum sends 10 lakh Covishield doses after 7-month halt

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo

UK recognises Covishield jab after India outcry

Contact nearby centres soon for 2nd dose of AstraZeneca: DGHS 

Contact nearby centres soon for 2nd dose of AstraZeneca: DGHS 

The United States had in February invoked the Defense Production Act, which gives the power to control the distribution of products, to curb the export of raw materials critical for vaccine production.(Representational photo)

WHO flags fake Covishield jabs in India, Africa

The study found that immunisation with a combination of an adenovirus vector platform-based vaccine followed by an inactivated whole virus vaccine was not only safe but also elicited better immunogenicity. Photo: UNB

Better immune response from mixing Covaxin, Covishield, says ICMR study

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo

'Covid recovered people with Covishield jabs safer against Delta variant': Study

A vial of AstraZeneca coronavirus disease (Covid-19) vaccine doses at a facility in Milton, Ontario, Canada, March 3, 2021. REUTERS/Carlos Osorio

Some European countries to allow travellers from India inoculated with Covishield

A vial of AstraZeneca coronavirus disease (Covid-19) vaccine doses at a facility in Milton, Ontario, Canada, March 3, 2021. REUTERS/Carlos Osorio

Covishield okayed by 7 EU Nations, Switzerland, Iceland

Accept Covishield, Covaxin or face mandatory quarantine, India tells EU

Accept Covishield, Covaxin or face mandatory quarantine, India tells EU

A man displays a vial AstraZeneca's COVISHIELD vaccine as the country receives its first batch of coronavirus disease (Covid-19) vaccines under COVAX scheme, in Accra, Ghana February 24, 2021. Photo: Reuters

African Union wants Covishield approved for EU Covid-19 certificate

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net